news

In the Media

2023-10-09 // Antimicrobial resistance biotech secures $37M with ex-CureVac CEO Franz-Werner Haas at the helm

Go to Article

2023-10-09 // Gates Foundation spends $40M to boost mRNA vaccine production in Africa and beyond

Go to Article

2022-02-10 // A small Seattle biotech wants to take on GlaxoSmithKline’s emerging Shingrix blockbuster

Go to Article

2022-02-07 // Univercells campus in Jumet ready to produce vaccines

Go to Article

2022-01-27 // Moderna, Excision each enter HIV battle with mRNA and CRISPR tech

Go to Article

2021-12-20 // The Gates Foundation brings new funding to Univercells

Go to Article